Verification opinion of Huatai United Securities Co., Ltd. on the use of part of the raised funds by Aojing Medical Technology Co., Ltd. to increase the capital of its wholly-owned subsidiary to implement the raised investment project.
Huatai United Securities Co., Ltd.'s inspection opinions on Aojing Medical Technology Co., Ltd.'s adjustment of the investment amount of some fund-raising projects, new fund-raising projects, and new implementing entities and implementation sites
Independent Director Candidate Statement
Independent Director Nominee Statement
Allgens Medical Technology: Announcement of Resolutions of the 9th Meeting of the 2nd Board of Supervisors
Allgens Medical Technology: Announcement on attending the 2023 Science and Technology Innovation Board Medical Consumables Special Group Performance Briefing and the 2024 First Quarter Results Briefing
Huatai United Securities Co., Ltd.'s inspection opinion on the initial public offering of some restricted shares of Aojing Medical Technology Co., Ltd.
Huatai United Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Aojing Medical Technology Co., Ltd.
Allgens Medical Technology: Investor Relations Activity Record Form - April 2024
Allgens Medical Technology: Special opinion of the board of directors on the independence of independent directors
Allgens Medical Technology: 2023 Accounting Firm Performance Assessment Report
Huatai United Securities Co., Ltd.'s special inspection opinion on the deposit and use of funds raised by Aojing Medical Technology Co., Ltd. in 2023
Huatai United Securities Co., Ltd.'s verification opinion on the use of some temporarily idle funds raised by Aojing Medical Technology Co., Ltd. for cash management
Allgens Medical Technology: 2023 Independent Director Debriefing Report (Li Xiaoming)
Allgens Medical Technology: 2023 Independent Director Debriefing Report (Zhao Lingyun)
Allgens Medical Technology: Resolutions of the first meeting of the 2nd Special Meeting of Independent Directors of the Board of Directors
Allgens Medical Technology: Special report on the storage and actual use of funds raised in 2023
Allgens Medical Technology: Announcement on the renewal of accounting firms
Allgens Medical Technology: Notice on the use of some temporarily idle funds raised for cash management
Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. independent financial advisory report on how Aojing Medical Technology Co., Ltd. granted part of the 2023 restricted stock incentive plan for the first time to meet the requirements for ownership during the first vesting period
No Data